Rochester, NY, United States of America

Elizabeth A Anderson

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of Rochester. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elizabeth A Anderson. Retrieved from https://idiyas.com/inventor/elizabeth-a-anderson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Elizabeth A Anderson in Peptide Design

Introduction

Elizabeth A Anderson is a notable inventor based in Rochester, NY (US). She has made significant contributions to the field of peptide design, particularly in the modulation of tight junction barriers. Her innovative work has implications for drug delivery and vaccine formulations.

Latest Patents

Elizabeth A Anderson holds 1 patent for her invention titled "Designed peptides for tight junction barrier modulation." This patent describes an agent that transiently disrupts claudin-1 within tight junctions. The agent includes a peptide with at least 40% polar, uncharged amino acid residues and a self-assembled β-sheet secondary structure. Additionally, her patent outlines transepithelial drug and vaccine formulations, isolated peptides, pharmaceutical compositions, and transdermal delivery devices. Methods for disrupting epithelial barriers and administering the described transepithelial formulations are also included.

Career Highlights

Elizabeth A Anderson is affiliated with the University of Rochester, where she continues her research and development in peptide design. Her work is at the forefront of innovations that enhance drug delivery systems and improve therapeutic outcomes.

Collaborations

Some of her notable coworkers include Benjamin L Miller and Anna De Benedetto, who contribute to her research endeavors and collaborative projects.

Conclusion

Elizabeth A Anderson's contributions to peptide design and tight junction modulation represent a significant advancement in biomedical research. Her innovative approaches have the potential to transform drug delivery and vaccine development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…